Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicentre study of Hyalgan-F in knee osteoarthritis
2005-002735-27Phase 3Completed
- Sponsor
- Fidia Farmaceutici
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of sodium hyaluronate in knee osteoarthritis (OA), sponsored by Fidia Farmaceutici. Primary endpoints: Immunogenicity of Hyalgan-F, General safety and 5 more. Started Sep 2005; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-002735-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002735-27.